ArticleClinical ophthalmology (Auckland, N.Z.)2013

Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients.

Steven A Nielsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.